Implant Vaccines Department Of Health Human Services Begin Implanting Vaccines Under The Skin

Department Of Health and Human Services  is developing technologies to transform vaccines to administer without the need for needles, syringes, and vials

https://www.ebolaoutbreakmap.com/listings/needle-free-vaccines/

Strategy

Help bring new technologies into the market that will replace the needle and syringe as the default modality. This includes technologies that:

• Use alternative delivery routes such as oral (swallowed, buccal, sublingual), inhaled (intranasal), transdermal, and implant (subcutaneous).
• Involve simplified logistics that facilitate easier deployment and uptake, and
• Enable administration without a trained healthcare professional.

What is Beyond The Needle?

Current vaccinations and therapeutics, involving injection of a liquid form via needle and syringe, place a tremendous burden on the healthcare system and supply chain, especially during a pandemic. Beyond the Needle is developing alternative technologies that aim to transform the paradigm making vaccines and therapeutics easier to administer and more widely available, without the need for needles, syringes, vials, and cold-chain distribution burdens.

Mission

Transform vaccination and other drug delivery by helping bring new technologies into market that offer alternative routes of administration so that needles and syringes are no longer the default modality, making them easier to administer, in a broader range of settings, without the need for needles, syringes, vials, and cold-chain transport. Beyond the Needle specifically aims to:

• Overcome the logistics burdens associated with manufacturing, storing, shipping and distributing needles, syringes, and other ancillary supplies, and also with cold-chain storage and transportation
• Increase immunization compliance, with pain-free, easier (possibly self-) administration and dose sparing for single-dose efficacy (vs. multiple boosters)
• Make vaccine more widely available, especially in resource-constrained settings and during a pandemic or other public health emergency where qualified healthcare professionals are in high demand and short supply

Strategy

Help bring new technologies into the market that will replace the needle and syringe as the default modality. This includes technologies that:

• Use alternative delivery routes such as oral (swallowed, buccal, sublingual), inhaled (intranasal), transdermal, and implant (subcutaneous).
• Involve simplified logistics that facilitate easier deployment and uptake, and
• Enable administration without a trained healthcare professional.